Prospectus

Prospectus

Jan 17, 2024

INVESTORS Prospectus Overview The Share Share Information Ownership Structure Financial Calendar Reports & Fillings Annual & Quarterly Reports Prospectus Old prospectus Analysts Events and Presentations FAQs Corporate governance Executive Team Board of...
Prospectus

Prospectus Terms

Jan 17, 2024

INVESTORS Prospectus Terms Overview The Share Share Information Ownership Structure Financial Calendar Reports & Fillings Annual & Quarterly Reports Prospectus Old prospectus Analysts Events and Presentations FAQs Corporate governance Executive Team Board of...
SAN2465

SAN2465

Jan 10, 2024

OUR PIPELINE SAN2465 – Rapid acting antidepressant  SAN2465 Rapid acting antidepressant devoid of psychotropic adverse effects SAN2465 is a highly potent and selective negative allosteric modulator (NAM) of GABAA α5 containing receptors with a pharmacological...
SAN2465

SAN2355

Jan 3, 2024

OUR PIPELINE SAN2355 – A selective Kv7.2/Kv7.3 activator SAN2355 – A selective Kv7.2/Kv7.3 activator Unprecedented subtype selectivity for treatment of epilepsy SAN2355 is the first clinical candidate from the Kv7 epilepsy program. SAN2355 is a subtype-selective...